SPX4,280.15+72.88 1.73%
DIA337.83+4.12 1.23%
IXIC13,047.19+267.27 2.09%

--B. Riley Lowers BioVie's Price Target to $12 from $18 Reflecting More Sharpened Focus of Target Model, Keeps Buy Rating

--B. Riley Lowers BioVie's Price Target to $12 from $18 Reflecting More Sharpened Focus of Target Model, Keeps Buy Rating

MT Newswires · 07/28/2022 06:04

Please log in to view news